D.E. Shaw & Co’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

D.E. Shaw & Co’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-30,000	Closed	-$373K	–	3796
2016 Q4	$373K	Hold	30,000	–	–	﹤0.01%	3012
2016 Q3	$411K	Buy	+30,000	New	+$301K	﹤0.01%	2891
2014 Q2	–	Sell	-11,500	Closed	-$93K	–	4766
2014 Q1	$93K	Sell	11,500 -100,300	-90%	-$781K	﹤0.01%	4179
2013 Q4	$762K	Buy	+111,800	New	+$604K	﹤0.01%	3396

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

D.E. Shaw & Co's ARIA Position: Q1 2017 in Review

D.E. Shaw & Co sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 65,062 shares — an estimated $809K sold.

D.E. Shaw & Co first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $7.33M in Q4 2015. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

D.E. Shaw & Co reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
D.E. Shaw & Co sold 65,062 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $809K.
D.E. Shaw & Co first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
D.E. Shaw & Co's Ariad Pharmaceuticals Inc position peaked at $7.33M in Q4 2015.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on D.E. Shaw & Co's 13F filing for Q1 2017, filed 15 May 2017.